Ro explains what is known about Zepbound and gastroparesis risk
Ro says Zepbound slows stomach emptying but isn't known to directly cause gastroparesis, and the research it cites suggests cases are rare.
Recap by typeshit. Full story at Ro.
Ro says Zepbound slows stomach emptying but isn't known to directly cause gastroparesis, and the research it cites suggests cases are rare.
Recap by typeshit. Full story at Ro.
BBC Global Women reports on a social media trend of taking weight-loss injections at far lower doses than prescribed.
Dr. Hamrah points out that 'peptide' covers everything from insulin to GLP-1s, and says the label alone tells you nothing about safety or evidence.
Ennis says no one asked about her surgical history or anemia before she began, and she later needed a transfusion. She lists questions clinicians should ask.
19:37
Dermatologist Dr Dray looks at the safety of popular injectable peptides like BPC-157 and TB-500 that are marketed for anti-aging.
NewBeauty shares the New York dermatologist's view on filler candidates. The excerpt gives no clear link to peptides or GLP-1 drugs.
Investseekers, citing MedWatch, says the new version carries three times the semaglutide of the current 2.4 mg Wegovy dose.
Loading…